{
  "ticker": "CRL",
  "year": 2024,
  "quarter": 3,
  "last_updated": "2025-04-19T09:36:19.551340",
  "count": 21,
  "transactions": [
    {
      "id": 91658,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 116313,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 142857,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 171462,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 202623,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 236111,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 272635,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-12",
      "transaction_shares": "2500",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "185751"
    },
    {
      "id": 91693,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 116348,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 142892,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 171500,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 202661,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 236149,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 272680,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-08-08",
      "transaction_shares": "1780",
      "transaction_price": "199.36",
      "transaction_type": "S",
      "shares_after_transaction": "22521"
    },
    {
      "id": 91648,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 116303,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 142847,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 171452,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 202613,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 236101,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    },
    {
      "id": 272624,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-08-01",
      "transaction_shares": "25000",
      "transaction_price": "250.00",
      "transaction_type": "S",
      "shares_after_transaction": "188251"
    }
  ]
}